4//SEC Filing
Desikan Nithya 4
Accession 0001104659-20-101370
CIK 0001649904other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:05 PM ET
Size
8.8 KB
Accession
0001104659-20-101370
Insider Transaction Report
Form 4
Desikan Nithya
Chief Commercial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2020-08-31−25,000→ 97,961 totalExercise: $6.88Exp: 2027-08-08→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2020-08-31$6.88/sh+25,000$172,000→ 68,602 total - Sale
Common Stock
2020-08-31$30.00/sh−25,000$750,000→ 43,602 total
Footnotes (2)
- [F1]On August 31, 2020, Ms. Desikan exercised and sold 25,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001714105
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:05 PM ET
- Size
- 8.8 KB